Gallen International Breast Cancer Conference established a consensus among experts regarding breast cancer classification based on immunohistochemical detection of key biomarkers such as estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor 2 (HER2), and Ki-67 (Goldhirsch et al., 2011). This evidence concerns the gene ESR1 and breast carcinoma.